Safety
-
Propecia (finastride) Tablet
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2011
ADVERSE REACTIONS
Postmarketing experience
- ...male breast cancer
-
-







